[HTML][HTML] Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
W Wang, L Wang, A Mizokami, J Shi, C Zou… - Chinese journal of …, 2017 - Springer
Background The chemoresistance of prostate cancer (PCa) is invariably associated with the
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
Down‐regulation of E‐cadherin enhances prostate cancer chemoresistance via Notch signaling
W Wang, L Wang, A Mizokami, J Shi… - Cancer …, 2017 - Wiley Online Library
Background The chemoresistance of prostate cancer (PCa) is invariably associated with the
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
W Wang, L Wang, A Mizokami, J Shi, C Zou… - Chinese Journal of …, 2017 - europepmc.org
Background The chemoresistance of prostate cancer (PCa) is invariably associated with the
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
[HTML][HTML] Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
W Wang, L Wang, A Mizokami… - Chinese …, 2017 - cancercommun.biomedcentral.com
The chemoresistance of prostate cancer (PCa) is invariably associated with the
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
[PDF][PDF] Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
W Wang, L Wang, A Mizokami, J Shi, C Zou, J Dai… - 2017 - core.ac.uk
Background: The chemoresistance of prostate cancer (PCa) is invariably associated with the
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
[PDF][PDF] Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
W Wang, L Wang, A Mizokami, J Shi, C Zou, J Dai… - 2017 - cyberleninka.org
Background: The chemoresistance of prostate cancer (PCa) is invariably associated with the
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
W Wang, L Wang, A Mizokami, J Shi, C Zou, J Dai… - 2017 - deepblue.lib.umich.edu
Background The chemoresistance of prostate cancer (PCa) is invariably associated with the
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
W Wang, L Wang, A Mizokami, J Shi… - Chinese journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The chemoresistance of prostate cancer (PCa) is invariably associated with the
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
W Wang, L Wang, A Mizokami, J Shi… - Cancer …, 2017 - search.proquest.com
Background The chemoresistance of prostate cancer (PCa) is invariably associated with the
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
[HTML][HTML] Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
W Wang, L Wang, A Mizokami, J Shi, C Zou… - Chinese Journal of …, 2017 - ncbi.nlm.nih.gov
Background The chemoresistance of prostate cancer (PCa) is invariably associated with the
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …
aggressiveness and metastasis of this disease. New emerging evidence indicates that the …